Glasgow launches Singapore MedTech fund to open Asia for Scottish spin-outs
What's the deal? The University of Glasgow has launched the MedTech Innovation Singapore Fund, a pilot connecting Scottish innovators with Singapore's healthcare and MedTech ecosystem. The programme aims to accelerate collaboration, commercialisation and international growth. It will support spin-outs and researchers as they explore opportunities across the Asia-Pacific region.
What does it do? Through the fund, Scottish innovators will test and validate technologies, understand local healthcare needs, and develop partnerships in Singapore and the wider region. The initiative connects entrepreneurs with healthcare providers, investors, innovation agencies and commercial partners.
Why now? As part of the pilot, Glasgow is working with Scottish Development InternationalDealroom has a profile for this one. Try Dealroom → to support a trade mission to the city state in February 2027. The move fits the university's broader strategy to foster more international partnerships.
The signal: Singapore is a competitive target: Asia-Pacific MedTech demand is forecast to reach US$132 billion by 2030, and recent moves—including MedtronicDealroom has a profile for this one. Try Dealroom →'s proposed investment of up to US$50 million in a regional innovation platform—signal intensifying competition for partnerships. Glasgow's pilot offers a relatively low-cost route for Scottish researchers to test products and assess entry into Asia; its success will hinge on whether it produces real commercial partnerships rather than just a trade mission.
Read more: gla.ac.uk
Image credit: Generated with Gemini
